jansitin duo 50 mg/1000 mg filmtabletta
g.l. pharma gmbh - a szitagliptin; metformin-hidroklorid -
lonamo duo 50 mg/850 mg filmtabletta
egis gyógyszergyár zrt. - a szitagliptin; metformin-hidroklorid -
lonamo duo 50 mg/1000 mg filmtabletta
egis gyógyszergyár zrt. - a szitagliptin; metformin-hidroklorid -
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , hármas kombinációs terápia) kiegészítéseként javasolt diéta, testmozgás, a betegek nem megfelelően ellenőrzött a maximálisan tolerálható dózis a metforminnal, illetve a szulfonilureával. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
mifomet 50 mg/850 mg filmtabletta
bausch health ireland ltd. - a szitagliptin; metformin-hidroklorid -
mifomet 50 mg/1000 mg filmtabletta
bausch health ireland ltd. - a szitagliptin; metformin-hidroklorid -
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , hármas kombinációs terápia) kiegészítéseként javasolt diéta, testmozgás, a betegek nem megfelelően ellenőrzött a maximálisan tolerálható dózis a metforminnal, illetve a szulfonilureával. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
montelukast cipla 4 mg rágótabletta
cipla (eu) ltd. - montelukast -
montelukast cipla 5 mg rágótabletta
cipla (eu) ltd. - montelukast -
telumantes 4 mg rágótabletta
sigillata ltd. - montelukast -